SANGAMO BIOSCIENCES, INC.

Patent Owner

Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12346
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 35212
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3186
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2964
 
 
 
C07K PEPTIDES 2981
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2075
 
 
 
A01H NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 7116
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS736
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 663
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5172

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0174,169 DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLSOct 16, 14Jun 25, 15[C12N, A61K]
2015/0166,618 METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIADec 09, 14Jun 18, 15[C12N, C07K]
2015/0159,172 METHODS AND COMPOSITIONS FOR GENOME ENGINEERINGDec 09, 14Jun 11, 15[C12N]
2015/0132,269 NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSIONNov 13, 14May 14, 15[C12N, A61K, C07K]
2015/0110,762 DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERINGOct 16, 14Apr 23, 15[C12N]
2015/0064,789 COMPOSITIONS FOR LINKING DNA-BINDING DOMAINS AND CLEAVAGE DOMAINSAug 28, 14Mar 05, 15[C12N, C07K]
2015/0067,921 FAD3 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKSSep 05, 13Mar 05, 15[C12N]
2015/0056,705 METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITIONMay 15, 14Feb 26, 15[C12N]
2015/0037,304 METHODS AND COMPOSITIONS FOR MODIFICATION OF HLAMar 12, 14Feb 05, 15[C12N, A61K]
2015/0031,090 METHODS AND COMPOSITIONS FOR TARGETED GENOMIC DELETIONSep 30, 14Jan 29, 15[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,045,763 Linear donor constructs for targeted integrationJun 16, 11Jun 02, 15[C12N, C07H]
9,005,973 Targeted genomic modification with partially single-stranded donor moleculesJul 08, 11Apr 14, 15[C12N, C12P]
8,962,281 Engineered cleavage half-domainsFeb 07, 11Feb 24, 15[C12N, C07H, C12P, C07K]
8,956,828 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesNov 10, 10Feb 17, 15[C12N, C07H, C12P, A61K]
8,945,868 Methods and compositions for modification of a HLA locusJul 21, 11Feb 03, 15[C12N, C12P, C07K]
8,936,936 Methods and compositions for targeted integrationOct 23, 08Jan 20, 15[C12N]
8,921,112 Optimized non-canonical zinc finger proteinsOct 01, 08Dec 30, 14[C12N, A01H]
8,912,138 DNA-binding proteins and uses thereofOct 28, 13Dec 16, 14[C12N, A61K]
8,895,264 locusOct 25, 12Nov 25, 14[C12N, C07H, C12Q, C07K]
8,889,390 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genesFeb 13, 13Nov 18, 14[C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0216,579 METHODS AND COMPOSTITIONS FOR GENE EDITING OF A PATHOGENABANJan 23, 13Aug 22, 13[C12N, C07K]
2013/0164,785 METHODS AND COMPOSITIONS FOR INACTIVATING GLUTAMINE SYNTHETASE GENE EXPRESSIONABANSep 06, 12Jun 27, 13[C07K]
2012/0214,241 ZINC FINGER NUCLEASE MODIFICATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) MUTANT FIBROBLASTS AND IPSCSABANDec 15, 11Aug 23, 12[C12N]
2012/0204,282 METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERSABANFeb 06, 12Aug 09, 12[C12N, C07H, A01K, A61P, A61K, C07K]
2012/0196,370 METHODS AND COMPOSITIONS FOR TARGETED GENOMIC DELETIONABANDec 02, 11Aug 02, 12[C12N]
2012/0088,677 METHODS AND COMPOSITIONS FOR ANALYSIS OF REGULATORY SEQUENCESABANDec 19, 11Apr 12, 12[C40B]
2011/0306,559 METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAINABANDec 23, 09Dec 15, 11[C12N, C07H, A61P, A61K, C07K]
2011/0281,937 Methods and compositions for treating neuropathic and neurodegenerative conditionsABANJan 03, 11Nov 17, 11[A61P, A61K]
2011/0244,474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsABANApr 28, 11Oct 06, 11[C12N, C07H, C12Q]
2011/0247,089 Organisms homozygous for targeted modificationABANApr 20, 11Oct 06, 11[C12N, A01K, A01H]
7,923,542 Libraries of regulatory sequences, methods of making and using sameExpiredOct 24, 01Apr 12, 11[C07H, C12Q, G01N]
2011/0014,616 Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsABANJun 29, 10Jan 20, 11[C12N, C07H, C12Q]
2010/0311,124 Methods and compositions for inactivating glutamine synthetase gene expressionABANJul 09, 10Dec 09, 10[C12N, C12P]
2010/0279,406 Alteration of tumor growth using zinc finger proteinsABANSep 20, 06Nov 04, 10[C12N]
2010/0261,271 Regulation of endogenous gene expression in cells using zinc finger proteinsABANSep 14, 06Oct 14, 10[C12N]
2010/0256,221 Methods and compositions for treating neuropathic and neurodegenerative conditionsABANOct 08, 09Oct 07, 10[A61P, A61K]
2010/0111,907 Methods and compositions for gene inactivationABANOct 15, 09May 06, 10[C12N, A61P, A61K]
2009/0305,402 Methods and compositions for using zinc finger endonucleases to enhance homologous recombinationABANJun 11, 09Dec 10, 09[C12N]
2009/0305,977 Method for treating peripheral arterial disease with zinc finger proteinsABANFeb 09, 07Dec 10, 09[A61K]
2009/0263,900 Linear donor constructs for targeted integrationABANApr 13, 09Oct 22, 09[C12N, C07H]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.